01763.HK
China Isotope & Radiation Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 15.30
−2.61%Year over year
Reported trailing growth
- Revenue
- +14.0%
- EBITDA
- +20.6%
- EBIT
- +11.1%
- EPS
- -5.0%
- Free cash flow
- -78.1%
- Operating cash flow
- -30.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.4%
- EBITDA
- +3.5%
- EBIT
- +0.1%
- Net income
- -6.7%
- EPS
- -6.7%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025